BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22419897)

  • 1. Breast Cancer-Associated Thrombotic Microangiopathy.
    Regierer AC; Kuehnhardt D; Schulz CO; Flath B; Jehn CF; Scholz CW; Possinger K; Eucker J
    Breast Care (Basel); 2011 Dec; 6(6):441-445. PubMed ID: 22419897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer.
    Morton JM; George JN
    J Oncol Pract; 2016 Jun; 12(6):523-30. PubMed ID: 27288467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy.
    Park YA; Hay SN; King KE; Matevosyan K; Poisson J; Powers A; Sarode R; Shaz B; Brecher ME
    J Clin Apher; 2009; 24(3):115-9. PubMed ID: 19260037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undiagnosed Metastatic Breast Carcinoma Presenting as Thrombotic Thrombocytopenic Purpura.
    Jackson DL; Coke L; Oni O; Taddesse-Heath L
    Cureus; 2023 Aug; 15(8):e44452. PubMed ID: 37791199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic Microangiopathy: A Rare Breast Cancer-associated Complication Treated Successfully With Doxorubicin and Cyclophosphamide.
    Jalali S; Jenneman D; Tandon A; Khong H
    In Vivo; 2021; 35(3):1885-1888. PubMed ID: 33910877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
    Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
    Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.
    Wada H; Matsumoto T; Suzuki K; Imai H; Katayama N; Iba T; Matsumoto M
    Thromb J; 2018; 16():14. PubMed ID: 30008620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frontline clinical practice for thrombotic thrombocytopenic purpura].
    Miyakawa Y
    Rinsho Ketsueki; 2020; 61(9):1331-1337. PubMed ID: 33162533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.
    Bommer M; Wölfle-Guter M; Bohl S; Kuchenbauer F
    Dtsch Arztebl Int; 2018 May; 115(19):327-334. PubMed ID: 29875054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine-Induced Thrombotic Microangiopathy Managed Conservatively in a Patient of Breast Cancer.
    Ghumman GM; Fatima H; Johnston TL; Leis R; Khatri V
    Cureus; 2022 Aug; 14(8):e28433. PubMed ID: 36176826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.
    Mousseaux C; Joly BS; Mohamadou I; Arrestier R; Hertig A; Rafat C
    BMC Nephrol; 2020 May; 21(1):204. PubMed ID: 32471388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Bittencourt CE; Ha JP; Maitta RW
    PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008.
    Fujimura Y; Matsumoto M
    Intern Med; 2010; 49(1):7-15. PubMed ID: 20045995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.